Verve's Sek Kathiresan on 2023 progress and working to bring base editing for LDL lowering to market

Moonwalk Biosciences raises $57 million today to pursue epigenome engineering

Moderna CEO Stéphane Bancel discusses what's ahead in 2024

Cytokinetics’ CEO Robert Blum discusses today’s SEQUOIA-HCM P3 result

Fauna Bio signs collaboration with Lilly to leverage understandings from hibernation to discover novel obesity targets

Using a covalent menin inhibitor as an approach against diabetes (and more) with Biomea Fusion's CEO

Apple Tree Partners funds a $52M Series A for Deep Apple to leverage virtual screening

Loyal founder Celine Halioua on the science of trying to help dogs live longer

Recapping #ASH23 with Syndax CEO Michael Metzger

Pyruvate kinase activation as a sickle cell disease strategy with Agios' CEO at #ASH23

Gracell's founder explains his company's rationale for BCMA + CD19 in both myeloma and lupus

Talking BTK degraders with the CEO of Nurix Therapeutics at #ASH23

Poseida's soon-to-be CEO on this morning's allo BCMA CAR-T data at #ASH23

Vertex COO Stuart Arbuckle on the approval and launch of CASGEVY for sickle cell disease at #ASH23

Incyte CEO Hervé Hoppenot on axatilimab for GvHD, BET inhibition, oral PD-1s and more from #ASH23

Protagonist Therapeutics' CEO on its hepcidin memetic at #ASH23 and oral IL23 program in I&I

Arcellx's CEO on Friday's #ASH23 topline release and his take on the BCMA field

Taking a deep dive into atopic dermatitis with the CEO of Apogee Therapeutics

Marianne De Backer talks about joining Vir Biotechnology and shares her vision for the future

Alto Neuroscience's CEO on why MDD data at #ACNP2023 may validate its precision medicine approach